Iluta S, Nistor M, Buruiana S, Dima D
Life (Basel). 2025; 15(2).
PMID: 40003637
PMC: 11856057.
DOI: 10.3390/life15020228.
Sravani A, Thomas J
Heliyon. 2025; 11(3):e41964.
PMID: 39959483
PMC: 11830326.
DOI: 10.1016/j.heliyon.2025.e41964.
Chung W, Zhang S, Atfi A, Xu K
Oncogene. 2024; 44(6):348-362.
PMID: 39548190
PMC: 11790384.
DOI: 10.1038/s41388-024-03226-7.
Netto D, Frizziero M, Foy V, McNamara M, Backen A, Hubner R
Curr Oncol. 2024; 31(9):5206-5223.
PMID: 39330013
PMC: 11430697.
DOI: 10.3390/curroncol31090385.
Musiu C, Lupo F, Agostini A, Lionetto G, Bevere M, Paiella S
Front Immunol. 2024; 15:1341079.
PMID: 38817612
PMC: 11137177.
DOI: 10.3389/fimmu.2024.1341079.
The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study.
Ayoub M, Faris C, Juranovic T, Chela H, Daglilar E
Cancers (Basel). 2024; 16(9).
PMID: 38730578
PMC: 11082986.
DOI: 10.3390/cancers16091625.
Cell of Origin of Pancreatic cancer: Novel Findings and Current Understanding.
Zheng C, Wang J, Wang J, Zhang Q, Liang T
Pancreas. 2024; 53(3):e288-e297.
PMID: 38277420
PMC: 11882172.
DOI: 10.1097/MPA.0000000000002301.
Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer.
Yan W, Menjivar R, Bonilla M, Steele N, Kemp S, Du W
Cancer Immunol Res. 2023; 12(1):91-106.
PMID: 37931247
PMC: 10842043.
DOI: 10.1158/2326-6066.CIR-23-0037.
Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer.
Marstrand-Dauce L, Lorenzo D, Chassac A, Nicole P, Couvelard A, Haumaitre C
Int J Mol Sci. 2023; 24(12).
PMID: 37373094
PMC: 10298625.
DOI: 10.3390/ijms24129946.
Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer.
Kondratyev M, Pesic A, Ketela T, Stickle N, Beswick C, Shalev Z
Commun Biol. 2023; 6(1):538.
PMID: 37202533
PMC: 10195806.
DOI: 10.1038/s42003-023-04828-9.
Pancreatic cancer: Advances and challenges.
Halbrook C, Lyssiotis C, Pasca di Magliano M, Maitra A
Cell. 2023; 186(8):1729-1754.
PMID: 37059070
PMC: 10182830.
DOI: 10.1016/j.cell.2023.02.014.
NOTCH Signaling in Osteosarcoma.
Zhang Z, Wu W, Shao Z
Curr Issues Mol Biol. 2023; 45(3):2266-2283.
PMID: 36975516
PMC: 10047431.
DOI: 10.3390/cimb45030146.
Inactivation of Attenuated Pancreatic Tumorigenesis in Mice.
Saeki K, Qiu W, Friedman R, Pan S, Lu J, Ichimiya S
Cancer Res Commun. 2023; 2(12):1601-1616.
PMID: 36970723
PMC: 10035463.
DOI: 10.1158/2767-9764.CRC-22-0106.
Epithelial and stromal co-evolution and complicity in pancreatic cancer.
Hingorani S
Nat Rev Cancer. 2022; 23(2):57-77.
PMID: 36446904
PMC: 10470605.
DOI: 10.1038/s41568-022-00530-w.
WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer.
Du W, Menjivar R, Donahue K, Kadiyala P, Velez-Delgado A, Brown K
J Exp Med. 2022; 220(1).
PMID: 36239683
PMC: 9577101.
DOI: 10.1084/jem.20220503.
Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype.
Liffers S, Godfrey L, Frohn L, Haeberle L, Yavas A, Vesce R
Gut. 2022; 72(3):522-534.
PMID: 35944927
PMC: 9933174.
DOI: 10.1136/gutjnl-2021-326550.
An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer.
Nisar M, Paracha R, Adil S, Qureshi S, Janjua H
Front Oncol. 2022; 12:875188.
PMID: 35686109
PMC: 9171400.
DOI: 10.3389/fonc.2022.875188.
The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids.
Choi J, Rim J, Jang S, Park J, Park H, Cho J
Theranostics. 2022; 12(9):4431-4445.
PMID: 35673567
PMC: 9169352.
DOI: 10.7150/thno.71364.
Current Pathology Model of Pancreatic Cancer.
Szymonski K, Milian-Ciesielska K, Lipiec E, Adamek D
Cancers (Basel). 2022; 14(9).
PMID: 35565450
PMC: 9105915.
DOI: 10.3390/cancers14092321.
Significant Roles of Notch -Glycosylation in Cancer.
Wang W, Okajima T, Takeuchi H
Molecules. 2022; 27(6).
PMID: 35335147
PMC: 8950332.
DOI: 10.3390/molecules27061783.